BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7055689)

  • 1. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
    Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
    Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute subcortical lesions modify cortical muscarinic receptors in human brain.
    Bracco L; Corradetti R; Amaducci L
    Neurosci Lett; 1982 Dec; 34(3):227-31. PubMed ID: 7162704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
    Nordberg A; Nyberg P; Windblad B
    Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of muscarinic cholinergic binding by lymphocytes in Parkinson's disease with and without dementia.
    Rabey JM; Grynberg E; Graff E
    Ann Neurol; 1991 Dec; 30(6):847-50. PubMed ID: 1789698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-dependent and stress-induced changes in rat hippocampal cholinergic system.
    Gilad GM; Rabey JM; Shenkman L
    Brain Res; 1983 May; 267(1):171-4. PubMed ID: 6860942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
    Friedman E; Gianutsos G; Kuster J
    J Pharmacol Exp Ther; 1983 Jul; 226(1):7-12. PubMed ID: 6864552
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-differences in choline acetyltransferase activities and muscarinic receptor binding in brain regions of C57BL/6J mice.
    Waller SB; London ED
    Exp Gerontol; 1983; 18(6):419-25. PubMed ID: 6673987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease.
    Nishino N; Fujiwara H; Noguchi-Kuno SA; Tanaka C
    Jpn J Pharmacol; 1988 Nov; 48(3):331-9. PubMed ID: 2851679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding.
    Morin AM; Wasterlain CG
    Neurochem Res; 1980 Mar; 5(3):301-8. PubMed ID: 7374884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of choline acetyltransferase, acetylcholinesterase, muscarinic receptor binding, and choline uptake in discrete areas of the rat medulla oblongata.
    Simon JR; Oderfeld-Nowak B; Felten DL; Aprison MH
    Neurochem Res; 1981 May; 6(5):497-505. PubMed ID: 7279110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD; Fields JZ; Yamamura HI
    Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscarinic agonist receptor subtypes in aging rat brain.
    Briggs RS; Petersen MM; Cook PJ
    Neurobiol Aging; 1982; 3(3):259-61. PubMed ID: 7162554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
    Ahlskog JE; Richelson E; Nelson A; Kelly PJ; Okazaki H; Tyce GM; van Heerden JA; Stoddard SL; Carmichael SW
    Ann Neurol; 1991 Aug; 30(2):185-91. PubMed ID: 1654766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.